Related Experiment Video
Updated: Sep 11, 2025

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
Internet-Based Behavioral Cough Suppression Therapy for Refractory Chronic Cough: A Randomized Controlled Trial.
Jane R Salois1, Kassidi L Heinle1, Laurie J Slovarp1
1School of Speech, Language, Hearing, & Occupational Sciences, University of Montana, Missoula.
Internet-based behavioral cough suppression therapy (IBCST) effectively reduced chronic cough symptoms in adults. Participants reported high satisfaction with the convenient, online treatment, showing significant improvements in quality of life.
Area of Science:
- Digital therapeutics
- Behavioral medicine
- Respiratory medicine
Background:
- Refractory chronic cough significantly impacts quality of life.
- Limited effective and accessible treatment options exist for chronic cough.
Purpose of the Study:
- To assess the efficacy of internet-based behavioral cough suppression therapy (IBCST).
- To explore patient experiences with IBCST for refractory chronic cough.
Main Methods:
- A 5-week randomized controlled trial compared IBCST with a healthy lifestyle control.
- Participants completed the Leicester Cough Questionnaire (LCQ) and Cough Severity Visual Analog Scale (VAS).
- Qualitative interviews explored user experiences with IBCST.
Main Results:
- 72% of IBCST participants showed clinically significant LCQ improvements at 1 week and 76% at 1 month.
- While VAS scores trended positively, they did not reach statistical significance.
- Qualitative data indicated high participant satisfaction with IBCST's convenience and effectiveness.
Conclusions:
- IBCST is a feasible and efficacious treatment for refractory chronic cough.
- IBCST demonstrates comparable efficacy to other behavioral cough suppression therapies.
- Findings support the adaptation of IBCST into a digital therapeutic.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

